索引超出了数组界限。
[1] Steinberg C, Nadeau-Routhier C, André P, et al. Ventricular
arrhythmia in septal and apical hypertrophic cardiomyopathy:
the French-Canadian experience[J]. Front Cardiovasc Med,
2020, 7:548564.
[2] 刘圆, 杨志健. 心尖肥厚型心肌病的研究进展[J]. 中国心血
管杂志, 2020, 25(1):82-85.
[3] Kim EK, Lee SC, Hwang JW, et al. Differences in apical
and non-apical types of hypertrophic cardiomyopathy: a
prospective analysis of clinical, echocardiographic, and
cardiac magnetic resonance findings and outcome from 350
patients[J]. Eur Heart J Cardiovasc Imaging, 2016, 17(6):678-
686.
[4] Eriksson MJ, Sonnenberg B, Woo A, et al. Long-term outcome
in patients with apical hypertrophic cardiomyopathy[J]. J Am
Coll Cardiol, 2002, 39(4):638-645.
[5] Towe EC, Bos JM, Ommen SR, et al. Genotype-phenotype
correlations in apical variant hypertrophic cardiomyopathy[J].
Congenit Heart Dis, 2015, 10(3):E139-E145.
[6] Klarich KW, Jost CH, Binder J, et al. Risk of death in
long-term follow-up of patients with apical hypertrophic
cardiomyopathy[J]. Am J Cardiol, 2013, 111(12):1784-1791.
[7] Chen CC, Lei MH, Hsu YC, et al. Apical hypertrophic
cardiomyopathy: correlations between echocardiographic
parameters, angiographic left ventricular morphology, and
clinical outcomes[J]. Clin Cardiol, 2011, 34(4):233-238.
[8] Hughes RK, Knott KD, Malcolmson J, et al. Apical
hypertrophic cardiomyopathy: the variant less known[J]. J Am
Heart Assoc, 2020, 9(5):e015294.
[9] Wu B, Lu M, Zhang Y, et al. CMR assessment of the left
ventricle apical morphology in subjects with unexplainable giant
T-wave inversion and without apical wall thickness ≥15 mm[J].
Eur Heart J Cardiovasc Imaging, 2017, 18(2):186-194.
[10] Flett AS, Maestrini V, Milliken D, et al. Diagnosis of apical
hypertrophic cardiomyopathy: T-wave inversion and relative
but not absolute apical left ventricular hypertrophy[J]. Int J
Cardiol, 2015, 183:143-148.
[11] Maron MS, Rowin EJ, Wessler BS, et al. Enhanced American
College of Cardiology/American Heart Association Strategy
for prevention of sudden cardiac death in high-risk patients
with hypertrophic cardiomyopathy[J]. JAMA Cardiol, 2019,
4(7):644-657.
[12] Hughes RK, Knott KD, Malcolmson J, et al. Advanced
imaging insights in apical hypertrophic cardiomyopathy[J].
JACC Cardiovasc Imaging, 2020, 13(2 Pt 2):624-630.
[13] 杨承健, 叶新和, 徐欣, 等. 心尖肥厚型心肌病超声诊断特点
及随访[J]. 中华内科杂志, 2010, 49(2):119-121.
[14] Rowin EJ, Maron BJ, Haas TS, et al. Hypertrophic
cardiomyopathy with leftventricular apical aneurysm:
implications for risk stratification and management[J]. J Am
Coll Cardiol, 2017, 69(7):761-773.
[15] Maron MS, Finley JJ, Bos JM, et al. Prevalence, clinical
significance, and natural history of left ventricular apical
aneurysms in hypertrophic cardiomyopathy[J]. Circulation,2008, 118(15):1541-1549.
[16] Huang G, Fadl S, Sukhotski S, et al. Apical variant
hypertrophic cardiomyopathy "multimodality imaging
evaluation"[J]. Int J Cardiovasc Imaging, 2020, 36(3):553-561.
[17] ?nlü S, ?zden Tok ?, et al. Differential diagnosis of apical
hypertrophic cardiomyopathy and apical displacement of the
papillary muscles: a multimodality imaging point of view[J].
Echocardiography, 2021, 38(1):103-113.
[18] Nagueh SF, Bierig SM, Budoff MJ, et al. American Society of
Echocardiography clinical recommendations for multimodality
cardiovascular imaging of patients with hypertrophic
cardiomyopathy:endorsed by the American Society of Nuclear
Cardiology, Society for Cardiovascular Magnetic Resonance,
and Society of Cardiovascular Computed Tomography[J]. J
Am Soc Echocardiogr, 2011, 24(5):473-498.
[19] Cardim N, Galderisi M, Edvardsen T, et al. Role of
multimodality cardiac imaging in the management of patients
with hypertrophic cardiomyopathy: an expert consensus of the
European Association of Cardiovascular Imaging Endorsed
by the Saudi Heart Association[J]. Eur Heart J Cardiovasc
Imaging, 2015, 16(3):280.
[20] Matsubara K, Nakamura T, Kuribayashi T, et al. Sustained
cavity obliteration and apical aneurysm formation in apical
hypertrophic cardiomyopathy[J]. J Am Coll Cardiol, 2003,
42(2):288-295.
[21] 宋光, 任卫东, 胡金玲, 等. 二维斑点追踪显像评价左室旋转
和扭转运动在早期心尖肥厚型心肌病诊断中的价值[J]. 中
国医科大学学报, 2015, 44(8):704-708.
[22] Inciardi RM, Galderisi M, Nistri S, et al. Echocardiographic
advances in hypertrophic cardiomyopathy: three-dimensional
and strain imaging echocardiography[J]. Echocardiography,
2018, 35(5):716-726.
[23] Authors/Task Force members, Elliott PM, Anastasakis A, et
al. 2014 ESC guidelines on diagnosis and management of
hypertrophic cardiomyopathy: the task force for the diagnosis
and management of hypertrophic cardiomyopathy of the
European Society of Cardiology (ESC)[J]. Eur Heart J, 2014,
35(39):2733-2779.
[24] Thind M, Joson M, Gaba S, et al. Incremental value of live/
real time three-dimensional transthoracic echocardiography
over two-dimensional echocardiography in hypertrophic
cardiomyopathy with mid-ventricular obstruction and apical
aneurysm[J]. Echocardiography, 2015, 32(3):565-569.
[25] Yang K, Song YY, Chen XY, et al. Apical hypertrophic
cardiomyopathy with left ventricular apical aneurysm:
prevalence, cardiac magnetic resonance characteristics,
and prognosis[J]. Eur Heart J Cardiovasc Imaging, 2020,
21(12):1341-1350.
[26] 赵涛. 磁共振成像在肥厚性心肌病中的临床应用研究[D].
北京: 北京协和医学院, 2013.
[27] Yin Y, Hu W, Zhang L, et al. Clinical, echocardiographic and
cardiac MRI predictors of outcomes in patients with apical
hypertrophic cardiomyopathy[J]. Int J Cardiovasc Imaging,
2022, 38(3):643-651.
[28] 王辉, 晏子旭, 姜红, 等. 心脏磁共振应变分析在临床前期心
尖肥厚型心肌病中的应用[J]. 中国医学影像学杂志, 2019,
27(1):1-5.
[29] Kim KH, Kim HK, Hwang IC, et al. Myocardial scarring
on cardiovascular magnetic resonance in asymptomatic
or minimally symptomatic patients with "pure" apical
hypertrophic cardiomyopathy[J]. J Cardiovasc Magn Reson,
2012, 14(1):52.
[30] Paluszkiewicz J, Krasinska B, Milting H, et al. Apical
hypertrophic cardiomyopathy: diagnosis, medical and surgical
treatment[J]. Kardiochir Torakochirurgia Pol, 2018, 15(4):246-
253.
[31] Habib M, Adler A, Fardfini K, et al. Progression of myocardial
fibrosis in hypertrophic cardiomyopathy[J]. JACC Cardiovasc
Imaging, 2021, 14(5):947-958.